REVIEW
Add like
Add dislike
Add to saved papers

Frontal sinus stenting.

Recurrence of frontal sinusitis following external and endoscopic intranasal drainage procedures has been and is presently a challenge to rhinologic surgeons. The complexity of the anatomy, especially with regard to size of the newly created frontal neo-ostium, directly influences long-term success. Frontal sinus stenting is indicated if the neo-ostium is less than 5 mm. Other important factors include excessive denuded bone, remnants of osteitic bone in the frontal recess, and severe mucosal disease as seen in allergic fungal sinusitis and nonallergic eosinophilic rhinitis. Lateralization of the middle turbinate and excessive removal of the middle turbinate have also been associated with recurrent frontal sinus disease. This article reviews previous frontal sinus stenting techniques and introduces a new soft self-retaining frontal sinus stent designed for endoscopic insertion.

Full text links

Management of Latent Tuberculosis Infection.JAMA 2023 January 20
How I Treat Multiple myeloma in the geriatric patient.Blood 2023 January 25

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app